Blog
What FDA Warning Letters Are and Why You Should Know About Them
Miraculous supplements? Be careful. The FDA publishes a list of companies selling illegal products. Check the Advisory Letters and avoid scams.
Tirso Najera · Apr 1, 2026
Blog
414 articles on leadership, communication and professional development.
Blog
The Oncology Radar: Summary of Latest FDA Approvals (November-December 2025)
Summary of FDA oncology approvals (Nov-Dec 2025): Updates in amyloidosis, lymphoma and leukemia. Stay up to date with new treatments.
Tirso Najera · Apr 1, 2026
Blog
A New Cellular Opportunity: FDA Approves Breyanzi for Marginal Zone Lymphoma
FDA approves Breyanzi (CAR-T) for relapsed marginal zone lymphoma. 84% response rate. New hope for adult patients.
Tirso Najera · Apr 1, 2026
Blog
How Artificial Intelligence is Revolutionizing Drug Development
The FDA drives the use of Artificial Intelligence in drug development. Learn how CDER regulates this innovation to create safe medicines.
Tirso Najera · Apr 1, 2026
Blog
Breakthrough in Gastric Cancer: FDA Approves Durvalumab (Imfinzi) for Resectable Stages
FDA approves durvalumab (Imfinzi) + chemotherapy for resectable gastric cancer. Improves survival and complete response. Details here.
Tirso Najera · Apr 1, 2026
Blog
Hope Against Leukemia: FDA Grants Traditional Approval to Pirtobrutinib (Jaypirca)
FDA approves pirtobrutinib (Jaypirca) for CLL and SLL in adults. Learn about the benefits, safety, and BRUIN study data in this article.
Tirso Najera · Apr 1, 2026
Blog
Accelerated Approvals in Cancer: How They Work and Why They Matter
Accelerated approvals: early access to cancer therapies based on initial evidence while confirmatory studies are completed.
Tirso Najera · Apr 1, 2026
Blog
What is Drug Trials Snapshots
Drug Trials Snapshots summarize studies of new medications and show who participated, their results and effects helping to better understand each treatment
Tirso Najera · Apr 1, 2026
Blog
Lynozyfic, the new treatment everyone is talking about
Lynozyfic offers a new option for treating multiple myeloma, with good clinical results and risks that require medical monitoring.
Tirso Najera · Apr 1, 2026
Blog
New treatment approved for immunoglobulin A nephropathy
New treatment for immunoglobulin A nephropathy that reduces proteinuria and offers a promising option while its effects are being evaluated.
Tirso Najera · Apr 1, 2026
Blog
What's Happening with Ozempic?
The FDA issued an important alert: they found counterfeit units of Ozempic within the official drug supply chain in the United States.
Tirso Najera · Apr 1, 2026
Blog
FDA Approves Darzalex Faspro (daratumumab) for High-Risk Smoldering Multiple Myeloma: What It Means and Who It Applies To
FDA approves Darzalex Faspro (daratumumab + hyaluronidase) for high-risk smoldering multiple myeloma; learn about AQUILA evidence, dosage, benefits and risks.
Tirso Najera · Apr 1, 2026
Blog
Storytelling Rockstars: A Practical Guide to Transforming Your KOLs, Sales Staff, and Rising Leaders into Inspiring Communicators
Practical guide to transform KOLs, sales teams, and leaders into memorable communicators who connect with their audience and drive action through storytelling.
Gerardo Betancourt · Apr 1, 2026
Blog
A Decision-Making System for Autonomous Leadership Environments
In 2024, Bayer incorporated the Dynamic Shared Ownership (DSO) model to gain agility.
Gerardo Betancourt · Apr 1, 2026
Blog
Integrity Talks: How Audi Used the Power of Ideas to Inspire Integrity in the Organization
Leaderlix joined forces with the integrity committee at Audi Mexico, made up of key leaders from Audi and Volkswagen, to orchestrate the Integrity program.
Gerardo Betancourt · Apr 1, 2026
Blog
How to Use Conversation Levels to Communicate with Impact
Learn to communicate with impact using Conversation Levels: avoid the expert's blind spot.
Gerardo Betancourt · Apr 1, 2026
Blog
Persuasion in Media: 4 Factors That Make Your Audience Believe You
Persuading in media is not magic: it's technique. Learn 4 key factors —cognitive fluency, nonverbal coherence, strategic structure, and medium adaptation— that make your audience believe you.
Gerardo Betancourt · Apr 1, 2026
Blog
Guide to Media Interviews: How to Persuade According to Format
Discover what changes when speaking with TV, radio, press, podcasts or social media. Compare formats, risks and audiences, and evaluate which media are your strongest.
Gerardo Betancourt · Apr 1, 2026
Blog
How to Predispose Trust in Your Audience Before a Media Interview
Learn how to predispose trust in your audience before a media interview using an Impact Bio: what it is, how to write it and present it.
Gerardo Betancourt · Apr 1, 2026
Blog
Why Do We Sometimes Hate Our Own Voice? The Science Behind the Phenomenon: Voice Confrontation
Explore in depth the phenomenon of voice confrontation: the neuroacoustic reason why your recorded voice sounds so different
Gerardo Betancourt · Apr 1, 2026